Heart failure (HF) represents a leading cause of morbidity and mortality. However, HF trials
highlighted many differences between men and women with HF. Thus, women represent …

Background Since novel coronavirus disease (COVID-19) emerged, various clinical features
of COVID-19 have been reported. Methods We conducted a systematic review of published …

Background Heart failure (HF) readmission rates are low in some jurisdictions. However,
international comparisons are lacking and could serve as a foundation for identifying …

Objective: Background incidence rates are routinely used in safety studies to evaluate an
association of an exposure and outcome. Systematic research on sensitivity of rates to the …

Introduction: Heart failure (HF) is a major cause of morbimortality both in men and women.
Differences between sex in etiopathogenesis, response to treatment, and quality of care …

Beta (β)-blockers (BB) are useful in reducing morbidity and mortality in patients with heart
failure (HF) and concomitant chronic obstructive pulmonary disease (COPD). Nevertheless …

Background: Multimorbidity represents a challenge for public health because as populations
age, its prevalence increases. The objectives were to describe by sex the multimorbidity …

Background: Transitional care may have different effects in males and females hospitalized
for heart failure. We assessed the sex-specific effects of a transitional care model on clinical …

Background Despite significant progress in cardiovascular disease (CVD) management, it
remains a public health priority and a global challenge. Within the disease process, health …

Sex-related differences among comorbid conditions associated with surgical site infection
(SSI) after total knee arthroplasty (TKA) are unclear. This population-based cohort study …